A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/29/2004	EP0996709B1 Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes
12/29/2004	EP0981332B1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
12/29/2004	EP0967892B1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
12/29/2004	EP0954527B1 Glycine transporter-transfected cells and uses thereof
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	EP0890361B1 HGF mutant and its use as an anticancer agent
12/29/2004	EP0858505B1 Cloning of vertebrate pheromone receptors and uses thereof
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	EP0722342B1 REGULATION OF bcl-2 GENE EXPRESSION
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	CN1558952A Pegylated and diglycosylated erythropoietin
12/29/2004	CN1558915A Leukocyte inactivation module
12/29/2004	CN1558914A Receptor, the use thereof, and mouse antibodies
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CN1558774A Angiotensin peptide-carrier conjugates and uses thereof
12/29/2004	CN1558772A Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
12/29/2004	CN1558771A Method for treating hepatitis c virus infection in treatment failure patients
12/29/2004	CN1558770A Method of preventing cell death using segments of neural thread proteins
12/29/2004	CN1558763A Treatment of hepatitis B virus infection with human monoclonal antibodies
12/29/2004	CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1558751A Method and composition for dry eye treatment
12/29/2004	CN1557954A Expression and application of transduction peptides - human insulinogen fusion protein
12/29/2004	CN1557951A Method for preparing non-receptor type tyrosine protein kinase Syk and use thereof
12/29/2004	CN1557835A Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same
12/29/2004	CN1557485A Application of gene recombined human lysozyme in eliminating pathogenic microorganism infection
12/29/2004	CN1557484A Chaenomeles fruit element contained lozenge and its preparation
12/29/2004	CN1557483A Allergy inhibiting prescription
12/29/2004	CN1557482A Immune function regulating and tumor resisting natural nutrient
12/29/2004	CN1557481A Natural nutrient for preventing and treating iron-deficiency anemia
12/29/2004	CN1557480A Preparation and application of insulin-like growth factors
12/29/2004	CN1557479A Interferon liposome emulsifiable paste
12/29/2004	CN1557478A Skin, connective tissue and bone growth promoting composition
12/29/2004	CN1557477A Sterile and freeze dried hypophysin preparation for injection and its preparing process
12/29/2004	CN1557476A Multiple biological activity polypeptide nutrient
12/29/2004	CN1557475A Beautifying and fat reducing nutrients composition
12/29/2004	CN1557474A Blood pressure reducing natural polypeptide nutrient
12/29/2004	CN1557473A Natural nutrient for preventing and treating hypertension and coronary heart disease
12/29/2004	CN1557472A Antineoplastic natural nutrient
12/29/2004	CN1557471A Nutrient for preventing and treating type II diabetes and X-syndrome
12/29/2004	CN1557470A Natural nutrient for preventing and treating multiple oral disease
12/29/2004	CN1557469A Natural calcium replenishing nutrient
12/29/2004	CN1557468A Preparation method and application of antiphlogistic factor
12/29/2004	CN1557467A Extraction and concentration combined pure Chinese medicinal preparation for treating cardiovascular diseases
12/29/2004	CN1557466A Marrow peptide preparation and its preparing process
12/29/2004	CN1557465A Spleen aminopeptide preparation and its preparing method
12/29/2004	CN1557464A 转移因子片剂 Transfer Factor Tablets
12/29/2004	CN1557388A Poisonous element content decreasing Kawa extracts and its composition and preparing method
12/29/2004	CN1557341A Preparing process of multiple biologically active substance containing formulation
12/29/2004	CN1557281A Skin apolexis preventing delaying polypeptide and compositions
12/29/2004	CN1182247C Sequence-specific DNA recombination in eukaryotic cells
12/29/2004	CN1182155C Recombinant human hepatocyte auxin, its preparing process and its clinical application
12/29/2004	CN1182154C Novel dolastatin derivatives, their preparation and use
12/29/2004	CN1182153C Novel dolastatin derivatives, their preparation and use
12/29/2004	CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004	CN1181889C Process for preparing oral insulin nano material
12/29/2004	CN1181888C Stable recombination human alpha interferon liquid preparation and productive process thereof
12/29/2004	CN1181887C Recombinant gamma-interferon for preventing and treating cow's recessive mammitis
12/29/2004	CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/29/2004	CN1181885C Administration of polypeptide growth factors after central nervous system ischemia or trauma
12/29/2004	CA2570407A1 Methods and compositions for modulating stem cell growth and differentiation
12/29/2004	CA2534748A1 Relaxin superfamily peptide analogues
12/29/2004	CA2532473A1 Amino acid supplementation for a healthy microbiota ecosystem
12/29/2004	CA2531671A1 Immune enhancing composition containing lactoferrin
12/29/2004	CA2530004A1 Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
12/29/2004	CA2529896A1 Hip/pap polypeptide composition for use in liver regeneration and for the prevention of liver failure
12/29/2004	CA2529852A1 Compositions for and methods for treating hiv
12/29/2004	CA2529847A1 Antiviral compositions and methods of using the same
12/29/2004	CA2529659A1 Engineered proteolytic enzyme with altered specificity determining regions
12/29/2004	CA2529589A1 New biological entities and the pharmaceutical or diagnostic use thereof
12/29/2004	CA2529105A1 Odor control compositions and methods
12/29/2004	CA2529056A1 Combinations of tumor-associated antigens in compositions for various types of cancers
12/29/2004	CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004	CA2528599A1 Proton-sensing g-protein coupled receptors and dna sequences thereof
12/29/2004	CA2527085A1 Synthetic peptide combinations and methods for the production thereof
12/29/2004	CA2526643A1 Use of a vegf receptor gene or gene product
12/29/2004	CA2526427A1 Clostridial toxins for treating eye disorders
12/29/2004	CA2526423A1 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure
12/29/2004	CA2526099A1 Freeze-dried fsh / lh formulations
12/29/2004	CA2526096A1 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
12/29/2004	CA2524256A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same
12/28/2004	US6835843 Amidation, deprotected by catalytic hydrogenation, salt formation with tributylamine
12/28/2004	US6835825 For regulating activation/development/differentiation of hematopoietic cells
12/28/2004	US6835823 Anti-TNF antibodies and peptides of human tumor necrosis factor
12/28/2004	US6835818 Mutants of Streptococcal toxin C and methods of use
12/28/2004	US6835817 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
12/28/2004	US6835812 Human p-Hyde proteins
12/28/2004	US6835811 Extended storage of reduced glutathione solutions
12/28/2004	US6835809 Thrombopoietic compounds
12/28/2004	US6835808 Anti-heparin peptides
12/28/2004	US6835806 Stable water soluble polypeptides which are potent inhibitors of endothelial cell proliferation and of angiogenesis.
12/28/2004	US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
12/28/2004	US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions
12/28/2004	US6835714 Heterocyclic compounds, intermediates thereof and elastase inhibitors
12/28/2004	US6835713 Peptide for use in the prevention and treatment of bacterial infections
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy

1 ... 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 ... 3163